Poxel Raises EUR10 Million from New Investors to Progress Clinical Development of Two Novel Type 2 Diabetes Therapies
Poxel SA announces today, that it has raised EUR10 million ($13.5 million) through a Series B extension with the Large V…
Poxel SA announces today, that it has raised EUR10 million ($13.5 million) through a Series B extension with the Large V…